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http://www.biomedcentral.com/1471-2431/14/299RESEARCH ARTICLE Open AccessThe etiologies of non-CF bronchiectasis in
childhood: a systematic review of 989 subjects
Kelly S Brower1, Michael T Del Vecchio1,2 and Stephen C Aronoff1,2*Abstract
Background: While cystic fibrosis (CF) is the most common cause of bronchiectasis in childhood, non-CF bronchiectasis
is associated with a wide variety of disorders. The objective of this study was to determine the relative prevalence
and specific etiologies on non-CF bronchiectasis in childhood.
Methods: EMBASE, Medline, OVID Cochrane Reviews, Directory of Open Access Journals, Open Science Directory,
EPSCO information services, and OAlster were searched electronically and the bibliographies of selected studies
were searched manually. The search was conducted independently by 2 authors. Study Selection: (1) any clinical
trial, observational study or cross-sectional case series of 10 or more patients with a description of the conditions
associated with bronchiectasis; (2) subjects aged 21 years or younger; (3) cystic fibrosis was excluded and; (4) the
diagnosis was confirmed by computed tomography of the chest. Data Extraction: Patient number, age range,
inclusion criteria, diagnostic criteria, patient source, and categorical and specific etiology.
Results: From 491 studies identified, 12 studies encompassing 989 children with non-CF bronchiectasis were
selected. Sixty-three percent of the subjects had an underlying disorder. Infectious (17%), primary immunodeficiency
(16%), aspiration (10%), ciliary dyskinesia (9%), congenital malformation (3%), and secondary immunodeficiency (3%)
were the most common disease categories; 999 etiologies were identified. Severe pneumonia of bacterial or viral
etiology and B cell defects were the most common disorders identified.
Conclusions: The majority of children with non-CF bronchiectasis have an underlying disorder. A focused history
and laboratory investigated is recommended.
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Bronchiectasis in children without cystic fibrosis (non-CF
bronchiectasis) is believed to be the end result of chronic
or repeated episodes of environmental insults superim-
posed on a background of ? genetic vulnerability? ; these
events lead to bronchial injury and dilatation [1]. In 1963,
Clark described 116 cases of bronchiectasis in children
aged 0 to 11 years [2]. See of those cases with an apparent
etiology, most followed episodes of measles or pertussis.
Radiographic evaluation of these children yielded a mixed
picture: 1 child had collapse of an entire lung; 12 children
had pulmonary cavitation with or without accompanying
atelectasis and; 34 children had lobar atelectasis. Broncho-
graphy demonstrated bronchiectasis in all subjects tested.* Correspondence: aronoff@temple.edu
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unless otherwise stated.The underlying ? vulnerabilities? in children are poorly
defined. McDonnell, et al. generated a list of disorders that
included immunodeficiency, connective tissue disorders,
allergic bronchopulmonary aspergillosis as well as miscel-
laneous conditions including amyloidosis and endometri-
osis [3]. In another review, autoimmune disorders, primary
ciliary dyskinesia, hypersensitivity syndromes, connective
tissue disorders, and malignancy were listed among the
potential causes of non-CF bronchiectasis [4]. In both
cases, the etiologies listed were not specific for children
and were not empirically derived. The goals of this system-
atic review were to determine the specific etiologies and
relative prevalence of these disorders among children
with non-CF bronchiectasis from studies reported in
the literature.td. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Protocol
This study followed the Preferred Reporting Items
in Systematic Reviews and Meta-Analyses (PRISMA)
guidelines [5].
Eligibility
The study protocol was developed by the authors a priori.
The inclusion criteria for this review were: (1) any clinical
trial, observational study or cross-sectional case series
of 10 or more patients that included a delineation of
the etiologies and/or the associated conditions with
bronchiectasis; (2) subjects aged 21 years or younger;
(3) cystic fibrosis was excluded as a diagnosis and; (4)
the diagnosis of bronchiectasis was confirmed by com-
puted tomography of the chest. Studies of adults and
children were acceptable if the pediatric data was re-
ported separately. Case reports, editorials and review
articles were excluded.
Information sources
EMBASE, Medline, OVID Cochrane Reviews, Directory of
Open Access Journals, Open Science Directory, EPSCO
information services, and OAlster were searched from
1966 to March 25, 2014. The bibliographies of all of the
selected studies were also reviewed.
Search
The main search term was ? non-CF bronchiectasis? . The
following filters were used: human, all children and young
adult. The searches were performed independently by two
of the authors and the results were compared.
Study selection
Initial evaluation of each article was performed by one
author (KSB) and then reviewed by another (MTD). In
cases where study populations appeared to overlap, the
study with the largest number of subjects was selected.
Differences in judgment were resolved first by consen-
sus; ties were adjudicated by the third author (SCA). All
studies selected for inclusion were reviewed by the third
author.
Data collection
For each selected study, the following information was
recorded: inclusion criteria, number of patients, age range,
diagnostic criteria, patient source and country of origin.
Categorical and specific etiologies of bronchiectasis were
also recorded for each study. Major categories of disease
included primary immunodeficiencies, ciliary dyskinesia,
infection, aspiration, idiopathic or unknown, congenital
malformation, secondary immunodeficiencies, asthma,
skeletal disorders, bronchiolitis obliterans, and others.Within each category, specific etiologies were catalogued
from those studies that provided specific data.
Synthesis of results
The categorical and specific etiologies of non-CF bron-
chiectasis were pooled to provide estimates of the relative
prevalence for each disorder. Total sample size estimates
for categorical comparisons were calculated from the total
number of etiologies identified for the entire review. Total
sample size estimates for the comparison of specific etiolo-
gies within individual categories were calculated from the
total number of etiologies reported in a given category.
Sources of bias across studies
Patient sampling by number, locale and institution raised
the concern of population homogeneity and possible
over- or under-representation of a specific area or ethnic
group. Variability in diagnostic evaluation and the identi-
fication of multiple etiologies for individual patients
were also potential sources of bias in defining etiology.
Inconsistencies and vagaries in nomenclature were a po-
tential source of error when studies were combined.
Results and discussion
Study selection
The results of the literature search are shown in Figure 1.
Searches of the Medline and EMBASE databases yielded
202 references. An additional 289 citations were found
by extensively searching the bibliographies of selected
articles (Additional file 1). No additional studies were
found by searching the OVID Cochrane Reviews, Direc-
tory of Open Access Journals, Open Science Directory,
EPSCO information services, or OAlster. From the 491
studies identified, 448 studies were excluded after a curs-
ory review of the title, abstract, and, when necessary, the
results section. The full text of the remaining 43 articles
was reviewed in detail. Thirty- one of the remaining
studies were excluded: 22 reports had overlapping popu-
lations with other studies; 3 did not use computed tom-
ography for the diagnosis of bronchiectasis; 1 did not have
the minimum number of patients; 2 studies included the
same subjects as previous publications; 2 included adult
populations that could not be separated from the pediatric
subjects and; 1 did not contain any etiology data.
Study characteristics and outcomes
The characteristics of the 12 studies that met the inclu-
sion criteria and comprise the basis of this review are
shown in Table 1 [6-17]. The reports ranged in size from
22 to 151 participants per study. Non-CF bronchiectasis
was defined by computed tomography [18]; in one study,
96% of patients underwent computed tomography [6].
Together, these reports represent a worldwide sample




















Figure 1 Results of literature search.
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http://www.biomedcentral.com/1471-2431/14/299New Zealand, Alaska, Italy, and Korea). Children were
drawn from single centers in 8 studies [6-12,16], mul-
tiple centers in 3 studies [13-15] and an entire region in
1 study [17]; the total number of patients included in
this review is 989.
The underlying conditions associated with non-CF
bronchiectasis in children, by study, are shown in Table 2.
Banjar, et al. and Eastham et al. reported multiple associa-
tions in individual patients [6,7]. Attempts to contact the
authors were unsuccessful. With the inclusion of these
studies, the total number of associations (994) exceeds
the total number of patients reported (989). In two
studies, the most likely association of multiple associa-
tions reported for individual patients was the only one
counted (e.g. primary immunodeficiency is a more likely
association than infection since it was the likely predis-
position for the infection) [7,8]. Singleton et al. described
patients with definite and probable bronchiectasis [16];
only definite cases were included.
Synthesis of results
The categorical disease processes associated with child-
hood non-CF bronchiectasis are shown in Table 3. Nine
hundred and ninety nine associations were identified in
989 patients. No association was found in 366 subjects
(40%). Of the identified associations, the most common
were infection (173 subjects, 19%), primary immunodefi-
ciency (160 subjects, 18%), aspiration/foreign body (95 sub-
jects, 10%) and ciliary dyskinesia, including Kartagener ? s
Syndrome (91 subjects, 10%).
The infections associated with non-CF bronchiectasis are
shown in Table 4. Of the 173 patients with an infectious
process, 108 (62%) were identified by a specific diseaseentity. Pneumonia was the most common association
(61%) followed by measles (14%), tuberculosis (11%) and
pertussis (5%). Varicella, neonatal pneumonia, allergic
bronchopulmonary aspergillosis and adenoviral pneu-
monia were rarely associated with bronchiectasis.
Of the 160 children with bronchiectasis and primary
immunodeficiency, 131 (83%) cases were identified by a
specific entity (Table 5). B cell disorders accounted for
97 (73.5%) of the primary immunodeficiencies identified:
IgG and IgG subclass deficiencies were the most common
(66.5%) and IgA deficiency accounted for 6%. A heteroge-
neous group of combined immunodeficiency disorders
accounted for 10% of cases while 7.5% of primary im-
munodeficiencies resulted from T cell disorders. Of the 29
subjects with secondary immunodeficiencies, 18 (62%)
were children who had received chemotherapy for an
underlying oncologic process; 6 (20%) of children had
HIV/AIDS and 5 (18%) were cardiac transplant recipients.
Of the 95 children with bronchiectasis and aspiration,
18 instances (20%) resulted from aspiration of a foreign
body; 14 children (15%) had seizures and recurrent aspir-
ation. Thirty-four children had an underlying congenital
malformation and 27 (79%) had a specific entity identified
(Table 6). Tracheoesophageal fistulae and cystic lung
disease accounted for 52% and 19% of cases, respectively.
Risk of bias
The studies included in this review ranged in size from
22 to 151 subjects; the largest study accounted for 17%
of the total sample. The countries of origin contributed
samples from 9 different countries and multiple conti-
nents. Only 1 study drew patients from a large, regional
database; the remaining studies represented one or two
Table 1 Summary of Included studies






Kapur et. al (2012) [9] Children < 18 years 113 3-195 months HRCT scan Single children? s
hospital
Australia
HRCT scan diagnosis of bronchiectasis
Availability of BAL fluid cytology
Microbiological results from bronchoscopy
No CF diagnosis
Zaid et. al (2010) [17] Children < 18 years with discharge diagnosis of chronic
bronchitis, bronchiectasis, or chronic suppurative lung
disease






Verified with chart review, exclusion of CF and
radiology review of HRCT
No CF diagnosis (sweat chloride < 60)
Karakoc et. al (2009) [11] Diagnosis of bronchiectasis based on suggestive clinical
and radiological features confirmed by HRCT
22 87.0 +/− 56.85 months [1] HRCT scan and clinical
diagnosis




Banjar (2007) [6] Non-CF bronchiectasis based on CXR and/or CT chest 151 7.3 +/− 4.1 years CXR Single center Saudi Arabia
CT chest (96%)
Li et. al (2005) [13] Database search bronchiectasis, chronic suppurative
lung disease, and chronic cough
136 3.1-18.1 years [2] HRCT scan Two centers United Kingdom
HRCT diagnosed bronchiectasis with suggestive clinical feature
No CF diagnosis (sweat test, genetic mutations, nasal
potential differences and faecal elastase if equivocal)
Karadag et. al (2005) [10] Patients with non-CF bronchiectasis confirmed with HRCT 111 7.4 +/− 3.7 years HRCT scan Single center Turkey
Eastham et. al (2004) [7] Children with bronchiectasis confirmed with HRCT 93 1.6-18.8 years HRCT scan Single center United Kingdom
Munro et. al (2011) [14] All children had HRCT and had at least 5 years
of follow up
91 0.9-16 years HRCT scan Database of single
children ? s hospital
New Zealand
Series of investigations to exclude CF and identify the
presumed etiology for bronchiectasis
Singleton et. al (2000) [16] Assessed by a pediatric pulmonologist to have definite
(CT findings) bronchiectasis [3]
28 1-15 years HRCT Two centers Alaska
Gaillard et. al (2003) [8] Database search identifying children with 2 or more
HRCT scans of the lungs in whom bronchiectasis was
reported in the first scan, then reviewed by a single
consultant radiologist
22 1-16 years [4] HRCT Single children? s
hospital
United Kingdom
Exclusion of CF patients
Koh et. al (1997) [12] Clinical features of bronchiectasis conformed
by CT and by bronchoscopy when necessary
25 13.1 +/− 2.6 years [2] Clinical plus CT Single clinic Korea









































Kapur et. al [9] 13 2 14 10 62 4 5 - - 3 -
11.50% 2% 12% 9% 55% 3.50% 4% 3%
Zaid et. al [17] 20 8 16 17 29 1 - - - 1 -
22% 9% 17% 18% 32% 1% 1%
Karakoc et. al [11] 2 1 9 - 6 - - 4 - - -
9.10% 4.50% 41% 27.20% 18.20%
Banjar et.al [6]. 27 21 6 19 60 11 2 - 10 - -
17.31% 13.46% 3.85% 12.18% 38.46% 7.05% 1.28% 6.41%
Li et. al [13] 40 20 5 25 35 5 6 - - - -
29.40% 14.70% 3.70% 18.40% 25.70% 3.70% 4.40%
Karadag et. al [10] 17 7 33 4 42 3 - 5 - - -
15.30% 6.30% 29.70% 3.60% 37.80% 2.70% 4.50%
Eastham et. al [7] 18 1 28 3 17 7 6 - - 8 5
19.35% 1.10% 30.10% 3.20% 18.30% 7.50% 6.45% 8.60% 5.40%
Munro et. al [14] 8 - 21 9 41 - 10 - 1 - 1
9% 23% 10% 45% 11% 1% 1%
Singleton et.al [16] - - 26 2 - - - - - - -
93% 7%
Gaillard et.al [8] 4 - 2 2 3 3 - 7 - - 1
18.20% 9.10% 9.10% 13.60% 13.60% 31.80% 4.60%
Koh et. al [12] - 6 6 - 13 - - - - - -
24% 24% 52%
Santamaria et. al [15] 11 25 7 4 58 - - - - - -


















Table 3 Summary of associations with non-CF
bronchiectasis of childhood by disease category
(989 patients with 994 associations)
Total number % of total
No association 308 34%
Infectious 174 19%
Primary immunodeficiency 158 17%
Aspiration/foreign body 91 10%
Primary ciliary dyskinesia 66 7%
Congenital malformation 34 4%
Secondary immunodeficiency 29 3%
Asthma 16 2%
Bronchiolitis obliterans 12 1%
Skeletal diseases 11 1%
Others 7 1%
Table 5 Primary immunodeficiencies associated with
non-CF bronchiectasis in childhood (n = 131)
Total number % of total
B cell disorders 97 74%
IgG deficiency* 63 48%
IgG subclass deficiency 24 18%
IgA deficiency 9 7%
B cell deficiency NOS 1 1%
T cell disorders 9 7%
Hyper IgE syndrome 3 2%
Hyper IgM syndrome 2 2%
T Cell deficiency 3 2%
Chronic mucocutaneous candidiasis 1 1%
Combined immunodeficiency 13 10%
Severe combined immunodeficiency** 9 7%
Ataxia-telangiectasia 2 2%
Wiskott-Aldrich syndrome 2 2%




Mannose-binding protein deficiency 1 1%
Other disorders 2 2%
*Includes patients identified as common variable immunodeficiency (30),
IgG deficiency (13), agammaglobulinemia (10) and antibody deficiency or
dysfunction (10).
**Not otherwise specified.
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http://www.biomedcentral.com/1471-2431/14/299clinical sites. All of the studies were retrospective in
nature and none employed a standardized diagnostic
evaluation. Vagaries in nomenclature occurred among
patients diagnosed with primary immunodeficiencies
deficiencies. Patients with antibody deficiency, antibody
dysfunction or IgG deficiency were grouped together as
IgG deficiency; those with combined immunodeficiency
were grouped together with severe combined immuno-
deficiency. Identifying patients with ? idiopathic? disease is
also confusing since this implies a singular, as yet uniden-
tified process. Three studies reported multiple underlying
disorders for individual patients with non-CF bronchiec-
tasis [6-8]. In two, patients with multiple ascribed etiolo-
gies could not be identified [6,7].
Non-CF bronchiectasis in children usually has an indo-
lent onset and presents with chronic respiratory symp-
toms [2-4]. Cough with daily sputum production is the
most common clinical presentation and may be presentTable 4 Infectious diseases associated with non-CF








Interstitial pneumonia 3 3%
Varicella 3 3%






*Severe viral or bacterial pneumonia.
**Pneumonia at age 6 months or less.for years before diagnosis. Hemoptysis, pleuritic chest
pain, pulmonary osteoarthropathy, and delayed growth are
additional findings associated with non-CF bronchiectasis.
The definitive diagnosis of bronchiectasis requires chest
imaging usually with high resolution computed tomog-
raphy [18].
While the pathophysiology of bronchiectasis is well
defined, the etiologies of non-CF bronchiectasis are
varied [1,3]. The data presented in this review suggest that
60% of children with this disorder have an underlyingTable 6 Congenital malformations associated with non-CF
bronchiectasis of childhood
Total number % of total
Tracheo-oesophageal fistula 14 52%
Cystic lung disease 5 19%
Bronchogenic cyst 2 7%
Yellow nail syndrome 1 4%
Tracheomalacia 1 4%
Congenital lobar emphysema 1 4%
Pulmonary artery sling 1 4%
Bronchial atresia 1 4%
Bronchomalacia 1 4%
Total 27
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ation (both foreign body and recurrent aspiration in neuro-
developmentally challenged patients) and ciliary dyskinesia
account for most cases; severe bacterial or viral pneumo-
nias and IgG deficiencies are the most common etiologies
encountered. Throughout the literature, patients without
an identified etiology are reported as idiopathic disease. A
focused medical history and focused laboratory investiga-
tion should reveal the etiology of non-CF bronchiectasis in
many cases.
Selection bias is a major limitation of this review.
Since all of the studies selected for review were retro-
spective in design, the possibility exists that patients may
have been missed. The subjects included in this study
represent 9 different countries, lending credence to the
notion that the sample is unbiased. Conversely, U.S. chil-
dren are underrepresented since the only American
study was from Alaska. Finally, 8 of the studies selected
for review reported patients from a single clinical site
and 3 studies used 2 clinical sites; only 1 study employed
a regional database [17].
Misidentification and failure to identify an etiology
also contribute to the limitation of this review. Identify-
ing multiple etiologies in individual patients occurred in
2 studies, raising the concern of over representation of
specific etiologies [6,7]. The selected studies contained
little to no detail regarding the diagnostic approach used
to identify the etiology of non-CF bronchiectasis. The
absence of a detailed, unified approach to the diagnostic
evaluation of these children across studies may have
overestimated the number of children without a diagnosis
or may have misdiagnosed an unknown number of sub-
jects. Variability in nomenclature compounds this prob-
lem. The most common etiology of non-CF bronchiectasis
was severe pneumonia, but detail regarding the infectious
agent was not available. The second most common eti-
ology was a B cell disorder; unfortunately some subjects
were identified with IgG deficiency or an antibody dis-
order leaving the true diagnosis open to speculation.
Conclusions
The majority of children with non-CF bronchiectasis have
an underlying cause of the disorder. Severe pneumonia, B
cell abnormalities, recurrent aspiration or aspiration of a
foreign body and ciliary dyskinesia are the most common
etiologies. A focused history and laboratory investigation
is suggested in the evaluation of these children. A large
prospective study with a predefined diagnostic evaluation
is required to substantiate the conclusions of this review.
Ethics
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